SOTAC PHARMACEUTICALS
|
Last 5 Year ShareHolding (%) History of SOTAC PHARMACEUTICALS
Last 8 Quarters| Mar2024 | Sep2023 | ||
|---|---|---|---|
| Promoter and Promoter Group | |||
| Indian Promoters | 72.85 % | 72.85 % | |
| Individuals / Hindu Undivided Family | 72.85 % | 72.85 % | |
| Central Government/State Government(s) | - | - | |
| Bodies Corporate | - | - | |
| Financial Institutions / Banks | - | - | |
| Partnership Firms | - | - | |
| Promoter Group | - | - | |
| Employees Welfare Fund | - | - | |
| Other | - | - | |
| Any Others (Specify) | - | - | |
| Foreign Promoters | - | - | |
| Non-Residents Individuals / Foreign Individuals | - | - | |
| 'Bodies Corporate | - | - | |
| Institutions | - | - | |
| Other | - | - | |
| Any Others (Specify) | - | - | |
| Total of Promoter and Promoter Group | 72.85 % | 72.85 % | |
| Pledged Promoter Holdings | 0 % | 0 % | |
| Public Shareholding | |||
| Institutions | 8.99 % | 8.52 % | |
| Mutual Funds / UTI | - | - | |
| Financial Institutions / Banks | - | - | |
| Insurance Companies | - | - | |
| Foreign Institutional Investors | - | - | |
| Venture Capital Funds | - | - | |
| Foreign Venture Capital Investors | - | - | |
| Alternate Investment Funds | - | - | |
| Foreign Portfolio investors | 8.99 % | 8.52 % | |
| Provident funds / Pension funds | - | - | |
| Multilateral & Bileteral Development Financial Institution | - | - | |
| Any Others (Specify) | - | - | |
| Central Government / State Government(s) | - | - | |
| Foreign Financial Institutions / Banks | - | - | |
| Stressed Assets Stabilisation Fund | - | - | |
| Foreign Financial Institutions | - | - | |
| State Finance Corporation | - | - | |
| Foreign Bodies DR | - | - | |
| Other | - | - | |
| Non-Institutions | 18.16 % | 18.64 % | |
| Bodies Corporate | 11.44 % | 12.60 % | |
| Individuals | - | - | |
| Individual shareholders holding nominal share capital up to Rs. 1 lakh | 3.43 % | 3.89 % | |
| Individual shareholders holding nominal share capital in excess of Rs. 1 lakh | 2.39 % | 1.43 % | |
| NBFCs Registed with RBI | - | - | |
| Employee Trusts | - | - | |
| Any Others (Specify) | - | - | |
| Clearing Members | - | - | |
| Non Resident Indians | 0.30 % | 0.28 % | |
| Directors & their Relatives & Friends | - | - | |
| Foreign Collaborators | - | - | |
| Foreign Mutual Fund | - | - | |
| Trusts | - | - | |
| Hindu Undivided Families | 0.60 % | 0.43 % | |
| Foreign Corporate Bodies | - | - | |
| Shares in transit | - | - | |
| Market Maker | - | - | |
| ESOP/ESOS/ESPS | - | - | |
| Societies | - | - | |
| Escrow Account | - | - | |
| Any Other | - | - | |
| Total Public Shareholding | 27.15 % | 27.15 % | |
| - | - | ||
| Total of Promoter and Public Shareholding | 100.00 % | 100.00 % |
Compare ShareHolding of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹137.2 Cr | -1.1% | 1.3% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
| CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -1.1% |
1.3% |
|
| SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses
